Adalta Ltd has released a press release.
Quarterly Review and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
Later from AdAlta
- Commercialisation Agreement with Crossbeta Biosciences
- Positive Pre-clinical Data
- AdAlta receives Orphan Designation for AD-114
- AdAlta expands partnership with Alfred Hospital
- Presentation of Eye Fobrosis Data at ARVO Meeting
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta